Murchinson Ltd. 180 Life Sciences Corp. Transaction History

Murchinson Ltd.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Nov 15, 2021	SELL	$5.11 - $10.81 $486,860 - $1.03 Million	-95,276 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$6.7 - $11.98 $638,349 - $1.14 Million	95,276 New	95,276 $953,000

Ticker ATNF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,698,900
Market Cap $141M
Description
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on f...

Get notified when there are updates to the investment portfolio of Murchinson Ltd., based on Form 13F filings with the SEC.

Stay updated on Murchinson Ltd. with notifications on news.